Publications by authors named "Axel Semjonow"

Claim this Profile
H
High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial.
Oliver Hommerding, Marit Bernhardt, Tobias Kreft, Anna Scherping, Mahmoud Abbas, Axel Semjonow

Virchows Arch· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance.
Ivo I de Vos, Daan Nieboer, Mark Frydenberg, Christian P Pavlovich, Mieke van Hemelrijck, Axel Semjonow

JAMA Netw Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
Okyaz Eminaga, Mahmoud Abbas, Christian Kunder, Yuri Tolkach, Ryan Han, Axel Semjonow

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies.
Chloe Gulliver, Sebastian Huss, Axel Semjonow, George S Baillie, Ralf Hoffmann

Br J Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Augmented Intelligence Framework for Bladder Lesion Detection.
Okyaz Eminaga, Timothy Jiyong Lee, Mark Laurie, T Jessie Ge, Vinh La, Axel Semjonow

JCO Clin Cancer Inform· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study.
Henk Benjamin Luiting, Sebastiaan Remmers, Egbert R Boevé, Riccardo Valdagni, Peter K Chiu, Axel Semjonow

Eur Urol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology Outcomes.
Chloe Gulliver, Sebastian Huss, Axel Semjonow, George S Baillie, Ralf Hoffmann

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer.
Katharina Besler, Aleksandra Węglarz, Laura Keller, Gunhild von Amsberg, Natalia Bednarz-Knoll, Axel Semjonow

Clin Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.
Sebastiaan Remmers, Jozien Helleman, Daan Nieboer, Bruce Trock, Matthew E Hyndman, Axel Semjonow

Eur Urol Open Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Thomas Steuber, Isabel Heidegger, Mona Kafka, Martin A Roeder, Felix Chun, Axel Semjonow

Eur Urol Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study.
Okyaz Eminaga, Eugene Shkolyar, Bernhard Breil, Axel Semjonow, Martin Boegemann

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.
Renata Poteska, Kambiz Rahbar, Axel Semjonow, Andres Jan Schrader, Martin Boegemann

BMC Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial.
Dorothee Tiedje, Matthias Borowski, Alexandra Simbrich, Kathrin Schlößler, Klaus Kruse, Axel Semjonow

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis.
Katrin Schlack, Laura-Maria Krabbe, Kambiz Rahbar, Karoline Isenberg, Axel Semjonow

Transl Androl Urol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression.
Paulina Nastały, Julia Smentoch, Marta Popęda, Emanuele Martini, Paolo Maiuri, Axel Semjonow

J Pers Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer.
Okyaz Eminaga, Mahmoud Abbas, Olaf Bettendorf, Axel Semjonow

World J Urol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR as a stable marker of prostate cancer dissemination to bones.
Paulina Nastały, Sara Stoupiec, Marta Popęda, Julia Smentoch, Thorsten Schlomm, Axel Semjonow

Br J Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer.
Okyaz Eminaga, Omran Al-Hamad, Martin Boegemann, Bernhard Breil, Axel Semjonow

Health Informatics J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.
Julia Smentoch, Jolanta Szade, Anna J Żaczek, Elke Eltze, Axel Semjonow

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Prospective Randomized Evaluation of a Decision Aid for Prostate-specific Antigen-based Early Detection of Prostate Cancer in Men Aged Between 55 and 69Yr: The PSAInForm Trial.
Axel Semjonow, Hans-Werner Hense, Kathrin Schlößler, Alexandra Simbrich, Matthias Borowski

Eur Urol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status.
Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, Sebastian Huss, Martin Bögemann, Axel Semjonow

Prostate Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.
Peter K-F Chiu, Chi-Fai Ng, Axel Semjonow, Yao Zhu, Sébastien Vincendeau

Eur Urol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCAness in prostate cancer.
Natalia Bednarz-Knoll, Elke Eltze, Axel Semjonow, Burkhard Brandt

Oncotarget· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Classification of Cystoscopic Images Using Deep Convolutional Neural Networks.
Okyaz Eminaga, Nurettin Eminaga, Axel Semjonow, Bernhard Breil

JCO Clin Cancer Inform· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study.
Andrew M Erickson, Stefano Luzzago, Axel Semjonow, Hanna Vasarainen, Teemu D Laajala

Eur Urol Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis